Rigel Pharmaceuticals Inc (RIGL) stock
RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$42.53−0.39 (-0.91%)
Close on Nov 18, 2026Market cap $794.46MP/E 2.7Yield –
Rigel Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Rigel Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2022 was -$74.21M, down 1513.2% year over year. For fiscal 2022 it was -$74.21M, down 1513.2% from the year before. The highest annual figure on record is $43.18M in fiscal 2010.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$74.21M | -1513.2% |
| FY2021 | Dec 31, 2021 | $5.25M | – |
| FY2020 | Dec 31, 2020 | -$53.45M | – |
| FY2019 | Dec 31, 2019 | -$42.97M | – |
| FY2018 | Dec 31, 2018 | -$59.93M | – |
| FY2017 | Dec 31, 2017 | -$77.72M | – |
| FY2016 | Dec 31, 2016 | -$76.69M | – |
| FY2015 | Dec 31, 2015 | -$23.96M | – |
| FY2014 | Dec 31, 2014 | -$70.17M | – |
| FY2013 | Dec 31, 2013 | -$87.30M | – |
| FY2012 | Dec 31, 2012 | -$88.59M | – |
| FY2011 | Dec 31, 2011 | -$71.68M | -266.0% |
| FY2010 | Dec 31, 2010 | $43.18M | – |
| FY2009 | Dec 31, 2009 | -$102.92M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -$21.98M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.49M | – |
| Q2 FY2022 | Jun 30, 2022 | -$12.88M | -123.5% |
| Q1 FY2022 | Mar 31, 2022 | -$25.86M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.07M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.47M | – |
| Q2 FY2021 | Jun 30, 2021 | $54.81M | – |
| Q1 FY2021 | Mar 31, 2021 | -$20.03M | – |
| Q4 FY2020 | Dec 31, 2020 | -$16.08M | – |
| Q3 FY2020 | Sep 30, 2020 | -$19.68M | – |
| Q2 FY2020 | Jun 30, 2020 | -$13.99M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.70M | – |
| Q4 FY2019 | Dec 31, 2019 | -$10.26M | -188.6% |
| Q3 FY2019 | Sep 30, 2019 | -$14.99M | – |
| Q2 FY2019 | Jun 30, 2019 | -$16.77M | – |
| Q1 FY2019 | Mar 31, 2019 | -$946.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $11.58M | – |
| Q3 FY2018 | Sep 30, 2018 | -$20.24M | – |
| Q2 FY2018 | Jun 30, 2018 | -$27.68M | – |
| Q1 FY2018 | Mar 31, 2018 | -$23.59M | – |
| Q4 FY2017 | Dec 31, 2017 | -$19.77M | – |
| Q3 FY2017 | Sep 30, 2017 | -$17.67M | – |
| Q2 FY2017 | Jun 30, 2017 | -$19.48M | – |
| Q1 FY2017 | Mar 31, 2017 | -$20.80M | – |
| Q4 FY2016 | Dec 31, 2016 | -$12.47M | – |
| Q3 FY2016 | Sep 30, 2016 | -$22.82M | – |
See a number that looks wrong?